FDA Inspection 1297050 — Daniel L. Peterson, MD
The FDA completed an inspection of Daniel L. Peterson, MD on December 12, 2025 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Austin, TX (United States)
Additional Details
Clinical Investigator (CI)